New research has found that long-term exposure to high blood pressure is associated with an increased risk of aortic valve disease, with significant implications for clinical practice guidelines and health management.
A new low dose three in one pill to treat hypertension could transform the way high blood pressure is treated around the world.
A trial led by The George Institute for Global Health revealed that most patients – 70 per cent – reached blood pressure targets with the ‘Triple Pill’, compared to just over half receiving normal care.
Providing access to free hospital care may not ensure equal access between women and men, an analysis of data on nearly 19 million households in South India by researchers at The George Institute for Global Health in India and at the University of Oxford suggests.
Dr Shobhana Nagraj, a doctoral student with The George Institute for Global Health at the University of Oxford, has been awarded a prestigious Clinical Research Training Fellowship by the UK’s Medical Research Council.